Search images on Google Product Monograph
Active Ingredients:
- fludeoxyglucose 18f, 0.5 GBQ/16 ML
DIN: 02412837
Dosage Form(s): SOLUTION
Route(s) of Administration: INTRAVENOUS
Schedule: Schedule C
Company: WINNIPEG REGIONAL HEALTH AUTHORITY
ATC:
- V09 - DIAGNOSTIC RADIOPHARMACEUTICALS (ATC, WHO, Wiki)
- V09I - TUMOUR DETECTION (ATC, WHO)
- V09IX - Other diagnostic radiopharmaceuticals for tumour detection (ATC, WHO)
- V09IX04 - FLUDEOXYGLUCOSE (18F) (WHO)